|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Current assets: | |||||||||||||
| Cash and cash equivalents | |||||||||||||
| Restricted cash | |||||||||||||
| Accounts receivable, net of allowance for doubtful accounts | |||||||||||||
| Deferred contract acquisition costs, current | |||||||||||||
| Prepaid expenses and other current assets | |||||||||||||
| Total current assets | |||||||||||||
| Property and equipment, net | |||||||||||||
| Right-of-use assets, net | |||||||||||||
| Deferred contract acquisition costs, non-current | |||||||||||||
| Restricted cash, non-current | |||||||||||||
| Prepaid marketing expense | |||||||||||||
| Other non-current assets | |||||||||||||
| Total assets | |||||||||||||
| Liabilities and Stockholders’ Equity | |||||||||||||
| Current liabilities: | |||||||||||||
| Accounts payable | |||||||||||||
| Accrued expenses | |||||||||||||
| Lease liabilities, current | |||||||||||||
| Deferred revenue | |||||||||||||
| Total current liabilities | |||||||||||||
| Lease liabilities, non-current | |||||||||||||
| Other non-current liabilities | |||||||||||||
| Total liabilities | |||||||||||||
| Redeemable common stock, $0.001 par value, 0 and 64,046,223 shares issued and outstanding at December 31, 2023 and 2022, respectively. | |||||||||||||
| Redeemable Common Stock | |||||||||||||
| Total redeemable common stock, $0.001 par value, 0 and 64,046,223 shares issued and outstanding at December 31, 2023 and 2022, respectively. | |||||||||||||
| Stockholders’ Equity | |||||||||||||
| Preferred stock: $0.001 par value; 100,000,000 shares authorized; 0 and 0 shares issued and outstanding at September 30, 2026, and December 31, 2025, respectively. | |||||||||||||
| Common stock | |||||||||||||
| Series A Common Stock | |||||||||||||
| Series B Common Stock | |||||||||||||
| Treasury stock: $0.001 par value; 29,243,958 and 0 shares held at September 30, 2026 and December 31, 2025, respectively | |||||||||||||
| Additional paid-in capital | |||||||||||||
| Accumulated deficit | |||||||||||||
| Total stockholders’ equity | |||||||||||||
| Total liabilities and stockholders’ equity | |||||||||||||
| Redeemable common stock, shares outstanding (in shares) | |||||||||||||
| Redeemable Common Stock | |||||||||||||
| Total redeemable common stock, shares outstanding (in shares) | |||||||||||||
| Preferred stock, shares outstanding (in shares) | |||||||||||||
| Common stock, shares issued (in shares) | |||||||||||||
| Series A Common Stock | |||||||||||||
| Series B Common Stock | |||||||||||||
| Common stock, outstanding (in shares) | |||||||||||||
| Series A Common Stock | |||||||||||||
| Series B Common Stock |
Loading...